CEO/Co-founder @LucidaMedical: AI to find cancer with MRI

Cambridge, England
Joined March 2013
Late breaking data on 40000 Aquablation procedures 🌍 at #SIU2024NewDelhi 🇮🇳 @PROCEPTRobotics “Aquablation has been studied in numerous countries and has shown reproducible results regarding safety, efficacy, and durability” 👍 @SIU_urology @pjscharlesworth @jteoh_hk
5
17
1,199
Fantastic reception for Prof Nikhil Vasdev's presentation at #SIU2024NewDelhi on how an integrated approach to AI in prostate MRI could support exciting improvements in accuracy @SIU_urology @nikhilvasdevuro @AWRix
3
5
502
This discussion on prostate cancer screening was an excellent session at a tremendous #ESUR24 conference. The perspective of the patient presenter - a prostate cancer survivor - was in stark contrast to the clinicians. (thread) 1/
Prof Valeria Panebianco is presenting to a packed conference room here at #ESUR24, discussing the state of the art in prostate cancer screening. @VPanebiancoIT @EsurOffice
1
2
162
I understand the risks, but I'm with the patients. MRI and targeted biopsy greatly reduce costs and harms of #prostate screening. Soon #AI like that of @LucidaMedical will further reduce costs and harms. I get my PSA tested and if it rises I would not hesitate to get an MRI. 5/
1
61
Patients are anxious for better, earlier diagnosis, weighting this far higher than treatment harms, and the presenter here advocated passionately for increased #prostatecancer #screening. 3/
1
7
For me: I understand the risks, but I'm with the patients. MRI, targeted biopsy and better treatments greatly reduce costs and harms of prostate screening. Soon #AI like that of @LucidaMedical will further reduce costs and harms. I
18
#ESUR2024 kicks off next week! We're looking forward to meeting you in Lisbon🇵🇹 Mark your calendars for Dr Francesco Giganti's abstract presentation, 16.00 on 19 Sept. If you'd like to see Pi™ (Prostate Intelligence) in action, visit the Lucida Medical stand! @EsurOffice #ESUR24
1
1
158
We asked @ProfPadhani to choose the most important practice breakthroughs in prostate cancer diagnosis in 2024. The below @TheLancet Commission lists interventions to tackle the surge in cases and shift the case mix from advanced to earlier-stage disease: thelancet.com/journals/lance…
1
6
6
808
Prof. Anwar Padhani discusses the evolving landscape of prostate cancer diagnosis. From early detection to patient preferences, @ProfPadhani explores the role of AI, and what changes to expect in future for the MRI diagnostic pathway. #ExpertInsights lucidamedical.com/latest-new…
5
1
8
894
Two weeks to go till #ESUR2024! See Dr Francesco Giganti present our abstract during Thursday's Scientific Session, from 16.00 on 19 September. Register here: lisbon2024.esur.org @ESUR_JN @EsurOffice @giga_fra #radtwitter #ESUR24
2
5
307
Today we are launching our #ProactiveforYourProstate campaign. It aims to put prostate cancer screening on the political agenda. We want to ensure everyone at high risk of developing the disease has the best chance to receiving an early diagnosis. Join us proactiveforyourprostate.co.…
1
4
2
4
528
Congratulations to the team @IUGroupplc @SmarterScanning on proposed acquisition of their AI business by @GEHealthCare. More details: intelligentultrasound.com/20…
Today, @GEHealthCare announced an agreement to acquire Intelligent Ultrasound's clinical AI business. This agreement unlocks an AI innovation pipeline that serves to help advance the future development of AI-enabled ultrasound technologies, bringing us closer to a world where healthcare has no limits. Learn more: bit.ly/3zR5b00 #AI #FutureofHealthcare #Ultrasound @SmarterScanning
57
Today, @GEHealthCare announced an agreement to acquire Intelligent Ultrasound's clinical AI business. This agreement unlocks an AI innovation pipeline that serves to help advance the future development of AI-enabled ultrasound technologies, bringing us closer to a world where healthcare has no limits. Learn more: bit.ly/3zR5b00 #AI #FutureofHealthcare #Ultrasound @SmarterScanning
5
32
11
55
7,771
🎯This is an excellent example of targeted, risk-adapted screening. With AI, carefully select mammography-negative women to invite for a screening MRI. Investigate those with suspicious MRI. Result: detecting cancer in 6.4% of those invited, with potentially life-saving benefit.
1/ Here is a breast AI risk assessment trial that I am truly excited about. The ScreenTrustMRI results were published in Nature Medicine. This study prospectively used AI to invite women for screening breast MRI, increasing the CDR to an enormous 64 per 1000 exams (compare to 16-18 for MRI, 5 for DBT). rdcu.be/dNc8I
1
1
4
224